Mintz Paul D, Anderson Garth, Avery Nancy, Clark Pamela, Bonner Robert F
University of Virginia Health System, Charlottesville, Virginia 22908, USA.
Transfusion. 2005 Aug;45(2 Suppl):72S-80S. doi: 10.1111/j.1537-2995.2005.00537.x.
There is continuing interest in the development of in vitro tests evaluating the in vivo function, recovery, and survival of platelets stored for transfusion. A recent forum concluded that no completely reliable test exists, although discoid morphology indicates a platelet's good health. We evaluated a novel device, the NAPSAC (Noninvasive Assessment of Platelet Shape and Concentration), designed to determine noninvasively the proportion of discoid platelets in a stored concentrate, as well as platelet concentration.
Twenty-eight plateletapheresis concentrates stored 24 hours in PL-146 were evaluated. Percent discoid platelet results were correlated with radiolabeled autologous recovery and survival performed using 111Indium oxyquinoline and calculated using linear (L) and multiple-hit (M) models. pH of 8 concentrates was raised at the end of storage with 6N NaOH. Platelet concentration measured by NAPSAC and Coulter Thrombocounter C was compared in 256 plateletapheresis products.
Percent discoid platelets at 24 hours did not correlate significantly with platelet recovery or survival (recovery L = 0.29, M = 0.28; survival L = 0.16, M = 0.03). Raising the pH (mean 6.38 to 6.94) resulted in a significant increase in percent discoid platelets (21% to 41%). Platelet concentration values for both methods studied were linearly correlated with a slope of 1.01 +/- 0.03, r = 0.81.
Percent discoid platelets was not predictive of posttransfusion platelet recovery or survival. The results suggest that non-discoid platelets may survive posttransfusion and even revert to discoid shape, since raising the pH approximately doubled the percent of discoid platelets. The NAPSAC was shown to be a reliable instrument for noninvasively determining platelet concentration in PL-146 concentrates.
对于开发评估用于输血储存的血小板的体内功能、恢复情况和存活率的体外测试一直存在兴趣。最近的一个论坛得出结论,尽管盘状形态表明血小板健康状况良好,但不存在完全可靠的测试方法。我们评估了一种新型设备,即NAPSAC(血小板形状和浓度无创评估仪),其设计目的是无创地确定储存浓缩物中盘状血小板的比例以及血小板浓度。
对28份在PL - 146中储存24小时的单采血小板浓缩物进行了评估。盘状血小板百分比结果与使用111铟氧喹啉进行的放射性标记自体恢复和存活率相关,并使用线性(L)模型和多击(M)模型进行计算。在储存结束时,用6N氢氧化钠提高8份浓缩物的pH值。在256份单采血小板制品中比较了通过NAPSAC和库尔特血栓计数器C测量的血小板浓度。
24小时时盘状血小板百分比与血小板恢复或存活率无显著相关性(恢复率L = 0.29,M = 0.28;存活率L = 0.16,M = 0.03)。提高pH值(平均从6.38提高到6.94)导致盘状血小板百分比显著增加(从21%增加到41%)。所研究的两种方法的血小板浓度值呈线性相关,斜率为1.01±0.03,r = 0.81。
盘状血小板百分比不能预测输血后血小板的恢复或存活率。结果表明,非盘状血小板可能在输血后存活甚至恢复为盘状形态,因为提高pH值使盘状血小板百分比增加了约一倍。NAPSAC被证明是一种可靠的仪器,可用于无创地测定PL - 146浓缩物中的血小板浓度。